K Number
K113845
Device Name
TUBING, CONMNECTORS, AND ACCESSORIES WIT BALANCE BIOSURFACE
Manufacturer
Date Cleared
2012-01-25

(28 days)

Product Code
Regulation Number
870.4290
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
Intended Use
This product is indicated for use in the extracorporeal circuit during cardiopulmonary bypass surgery procedures.
Device Description
Tubing, Connectors, and Accessories with Balance™ Biosurface are used in cardiopulmonary bypass for connecting the primary devices of the bypass circuit. The functionality and intended use of these devices are the same as those for the coated (Trillium® Biosurface) and uncoated tubing, connectors, and accessories that are FDA cleared. Balance™ Biosurface has been previously FDA cleared (K100646) and is commercially available. Balance™ Biosurface is a non-leaching biocompatible surface that reduces platelet adhesion and activation and preserves platelet function.
More Information

Not Found

No
The description focuses on the physical components and surface coating of the device, with no mention of AI or ML capabilities.

No.
The product is described as tubing, connectors, and accessories used in cardiopulmonary bypass for connecting primary devices, not as a device that treats a disease or condition itself.

No

The device is described as tubing, connectors, and accessories used in extracorporeal circuits for cardiopulmonary bypass surgery. Its functionality is to connect primary devices, reduce platelet adhesion, and preserve platelet function, not to diagnose medical conditions.

No

The device description clearly states it is comprised of "Tubing, Connectors, and Accessories," which are physical hardware components, not software.

Based on the provided text, this device is not an IVD (In Vitro Diagnostic).

Here's why:

  • Intended Use: The intended use is "in the extracorporeal circuit during cardiopulmonary bypass surgery procedures." This describes a device used during a medical procedure on a patient, not a device used to test samples outside the body to diagnose a condition.
  • Device Description: The description focuses on the physical components (tubing, connectors, accessories) and their function in connecting other devices in the bypass circuit. It also highlights a surface coating that affects blood components within the circuit. This is consistent with a medical device used in a surgical setting, not an IVD.
  • Lack of IVD Characteristics: The text does not mention any of the typical characteristics of an IVD, such as:
    • Analyzing biological samples (blood, urine, tissue, etc.)
    • Detecting or measuring specific substances (analytes)
    • Providing information for diagnosis, monitoring, or prognosis of a disease or condition

Therefore, this device falls under the category of a medical device used in a surgical procedure, not an In Vitro Diagnostic device.

N/A

Intended Use / Indications for Use

The Medtronic Custom Perfusion System is indicated for use in the extracorporeal circuit during cardiopulmonary bypass surgery procedures.

Product codes (comma separated list FDA assigned to the subject device)

DWF, DTL

Device Description

Tubing, Connectors, and Accessories with Balance™ Biosurface are used in cardiopulmonary bypass for connecting the primary devices of the bypass circuit. The functionality and intended use of these devices are the same as those for the coated (Trillium® Biosurface) and uncoated tubing, connectors, and accessories that are FDA cleared. Balance™ Biosurface has been previously FDA cleared (K100646) and is commercially available. Balance™ Biosurface is a non-leaching biocompatible surface that reduces platelet adhesion and activation and preserves platelet function.

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Not Found

Anatomical Site

Not Found

Indicated Patient Age Range

Not Found

Intended User / Care Setting

Not Found

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)

Verification and validation testing has demonstrated that the tubing, connectors, and accessories with Balance™ Biosurface are substantially equivalent to the predicates. The following performance tests were conducted:
Balance™ Biosurface coverage - Pass
Balance™ Biosurface leaching - Pass
Hemolysis - Pass
White Blood Cell (WBC) Retention - Pass
Platelets Retention/ Platelet Activation - Pass
Kallikrein Generation - Pass
Tubing kink resistance - Pass
Pressure integrity - Pass
Pressure decay - Pass
Tubing pull force - Pass
No tubing pull off during static force - Pass
Tubing Life - Pass
Tubing Spallation - Pass
Biocompatibility Assessment - Pass - no impact to biocompatibility
Packaging and Sterilization Assessment - Pass - no impact to packaging and sterilization
Shelf-Life Verification - Pass

Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)

Not Found

Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.

K800178, K883956, K924529, K012538, K100646

Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.

Not Found

Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).

Not Found

§ 870.4290 Cardiopulmonary bypass adaptor, stopcock, manifold, or fitting.

(a)
Identification. A cardiopulmonary bypass adaptor, stopcock, manifold, or fitting is a device used in cardiovascular diagnostic, surgical, and therapeutic applications to interconnect tubing, catheters, or other devices.(b)
Classification. Class II (special controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 870.9.

0

K113845 pa 10+ 3

JAN 2 5 2012

510(k) Summary of Safety and Effectiveness

Date Prepared:December 22, 2011
Submitter:Medtronic, Inc.
Medtronic Perfusion Systems
611 Northland Drive
Minneapolis, MN 55428
Contact Person:Kevin T. Lam
Senior Regulatory Affairs Specialist
Medtronic Perfusion Systems
Phone: 763-526-2360
Fax: 763-367-8360
E-Mail: kevin.t.lam@Medtronic.com
Alternate contact:
Sue Fidler
Senior Regulatory Affairs Manager
Medtronic Perfusion Systems
Phone: 763-514-9839

Fax:

Device Name and Classification:

Trade Name:Tubing, Connectors and Accessories with Balance™ Biosurface
Common Name:Cardiopulmonary bypass adapter tubing, connector, stopcock, manifold or fitting
Regulation Number:21 CFR 870.4290
Product Code:DWF and DTL
Product Code:Class II

763-367-8360

E-Mail: susan.c.fidler@medtronic.com

Predicate Devices

Intersept Custom Tubing Pack (K800178) Bio-Medicus Tubing Connectors (K883956) Signature Custom Tubing Pack (K924529) Trillium Coated Tubing and Connectors (K012538) Affinity Pixie™ Arterial Filter with Balance™ Biosurface (K100646)

Device Description

Tubing, Connectors, and Accessories with Balance™ Biosurface are used in cardiopulmonary bypass for connecting the primary devices of the bypass circuit. The

1

K113845 pg 2 of 3

functionality and intended use of these devices are the same as those for the coated (Trillium® Biosurface) and uncoated tubing, connectors, and accessories that are FDA cleared. Balance™ Biosurface has been previously FDA cleared (K100646) and is commercially available. Balance™ Biosurface is a non-leaching biocompatible surface that reduces platelet adhesion and activation and preserves platelet function.

Intended Use

There is no change to the indication for use for these devices/components.

The Medtronic Custom Perfusion System is indicated for use in the extracorporeal circuit during cardiopulmonary bypass surgery procedures.

Comparison to Predicate Devices

A comparison of the modified product and the currently marketed tubing, connectors, and accessories with Trillium® Biosurface (K012538), Intersept Custom Tubing Pack (K800178), Bio-Medicus Tubing Connectors (K883956), and Signature Custom Tubing Pack (K924529) indicates the following similarities to the product which received 510/k) clearance:

  • ◆ Same intended use
  • . Same technological characteristics
  • Same operating principle .
  • Same design features (with the exception that Balance™ Biosurface will not contain . heparin in the coating)
  • Same base materials prior to coating .
  • Same shelf life .

A comparison of the modified product and the currently marketed Affinity Pixie™ Arterial Filter with Balance™ Biosurface (K100646) indicates the following similarities to the product which received 510(k) clearance:

  • Same Balance™ Biosurface coating .

Summary of Performance Data

Verification and validation testing has demonstrated that the tubing, connectors, and accessories with Balance™ Biosurface are substantially equivalent to the predicates. The following performance tests were conducted:

Verification/ValidationResults
Balance™ Biosurface coveragePass
Balance™ Biosurface leachingPass
HemolysisPass
White Blood Cell (WBC) RetentionPass
Platelets Retention/ Platelet ActivationPass
Kallikrein GenerationPass
Tubing kink resistancePass

2

Pressure integrityPass
Pressure decayPass
Tubing pull forcePass
No tubing pull off during static forcePass
Tubing LifePass
Tubing SpallationPass
Biocompatibility AssessmentPass - no impact to biocompatibility
Packaging and Sterilization AssessmentPass - no impact to packaging and sterilization
Shelf-Life VerificationPass

Conclusion

Medtronic has demonstrated that the tubing, connectors, and accessories with Balance™ Biosurface for use in custom perfusion system are substantially equivalent to the predicate devices based upon design, test results and indications for use. The fundamental scientific principle, labeling and the intended use are unchanged as a result of these device modifications.

3

Image /page/3/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo features a stylized eagle or bird-like symbol with three curved lines representing its body and wings. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular fashion around the bird symbol.

Food and Drug Administration 10903 New Hampshire Avenue Document Control Room -WO66-G609 Silver Spring, MD 20993-0002

JAN 2 5 2012

Medtronic, Inc. c/o Mr. Kevin T. Lam Senior Regulatory Affairs Specialist Medtronic Perfusion Systems 7611 Northland Drive Minneapolis, MN 55428

Re: K113845

Trade/Device Name: Tubing, Connectors, and Accessories with Balance™ Biosurface Regulation Number: 21 CFR 870.4290 Regulation Name: Cardiopulmonary bypass adaptor, stopcock, manifold, or fitting Regulatory Class: Class II Product Code: DTL Dated: December 22, 2011 Received: December 28, 2011

Dear Mr. Lam:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be

4

Page 2 - Mr. Kevin T. Lam

found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to

http://www.fda.gov/MedicalDevices/Safety/ReportalProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address.

http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.

Sincerely yours,

M.A. Killebrew

്യം Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

5

K113845

Indications for Use Statement

510(k) Number (if known): _K113845

Device Name: Tubing, Connectors, and Accessories with Balance™ Biosurface

Indications for Use:

This product is indicated for use in the extracorporeal circuit during cardiopulmonary bypass surgery procedures.

Prescription Use × (Part 21 CFR 801 Subpart D) AND/OR

Over-The-Counter Use (21 CFR 801 Subpart C)

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

.y. Kleban

(Division Sian-Off) (Division of Cardiovascular Devices

k11 3845 510(k) Number_